marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Rocket Pharmaceuticals Income Statement 2011-2024 | RCKT
Annual Income Statement Rocket Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.6 B | 1.3 B | 1.05 B | 3.05 B | 1.08 B | 548 M | 117 M | 41.4 M | 143 M | - | - | - | - |
Shares |
84 M | 68.1 M | 63.2 M | 55.4 M | 49 M | 39.4 M | 6.77 M | 6.68 M | 4.58 M | - | - | - | - |
Historical Prices |
30.9 | 19.1 | 16.6 | 55.1 | 20.5 | 14.4 | 19 | 6.4 | 31.3 | - | - | - | - |
Net Income |
-246 M | -222 M | -169 M | -140 M | -77.3 M | -74.5 M | -29.5 M | -42.9 M | -68 M | -9.53 M | -7.62 M | -6.06 M | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-260 M | -224 M | -167 M | -134 M | -76.2 M | -71.2 M | -19.8 M | -7.57 M | -20.4 M | -7.7 M | - | - | - |
Interest Expense |
1.88 M | 1.86 M | 2.98 M | 6.97 M | 5.96 M | 6.04 M | - | - | 1.23 M | 980 K | - | - | - |
EBITDA |
-255 M | -220 M | -164 M | -134 M | -75.7 M | -70.8 M | -26.5 M | -41.7 M | -20.4 M | -7.7 M | -6.65 M | -5.84 M | - |
Operating Expenses |
260 M | 224 M | 167 M | 134 M | 76.2 M | 71.2 M | 26.7 M | 41.9 M | 20.4 M | - | - | - | - |
General and Administrative Expenses |
73.3 M | 58.8 M | 41.8 M | 28.9 M | 17.5 M | 17.9 M | 12.5 M | 9.89 M | 7.84 M | 2.11 M | 1.32 M | 2.31 M | - |
All numbers in USD currency
Quarterly Income Statement Rocket Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
94.2 M | 93.7 M | 93.5 M | 90.3 M | 82.6 M | 80.5 M | 79.5 M | 79.1 M | 66.2 M | 65.5 M | 64.5 M | 64.5 M | 63.8 M | 63.1 M | 61.6 M | 61 M | 55.2 M | 55.2 M | 54.9 M | 54.8 M | 50.4 M | 49.3 M | 45.1 M | 45.1 M | 39.9 M | 39.5 M | 36.1 M | 6.8 M | 6.8 M | 6.8 M | 6.8 M | 6.75 M | 26.9 M | 26.6 M | 26.4 M | 26.4 M | 22.6 M | 16.3 M | 7.68 M | 1.02 M | 1.02 M | 1.02 M | 1.02 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-66.7 M | -69.6 M | -62.1 M | - | -61.9 M | -65.7 M | -58.3 M | - | -57.8 M | -54.4 M | -43 M | - | -50.1 M | -34.5 M | -40.2 M | -60.9 M | -29.1 M | -25 M | -24.7 M | -19.9 M | -19.3 M | -18.7 M | -19.5 M | -27.3 M | -16.1 M | -15.8 M | -15.3 M | -6.66 M | -6.72 M | -3.52 M | -2.68 M | - | -11.1 M | -8.68 M | -10.1 M | - | -56 M | -2.39 M | -1.46 M | - | -2.39 M | -2.85 M | -2.15 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-69.4 M | -73.7 M | -67.4 M | - | -65.4 M | -68.8 M | -62.2 M | - | -58.5 M | -54.2 M | -42.6 M | - | -49.6 M | -34 M | -39.2 M | -59.2 M | -27.4 M | -23.6 M | -24.1 M | -19.6 M | -19.2 M | -18.4 M | -18.9 M | -26.5 M | -15.3 M | -14.9 M | -14.4 M | -6.66 M | -6.72 M | -3.52 M | -2.87 M | - | -10.7 M | -8.78 M | -10.1 M | - | -5.44 M | -3.68 M | -3.05 M | - | -2.09 M | -2.19 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
471 K | 471 K | 471 K | - | 469 K | 468 K | 468 K | - | 465 K | 465 K | 464 K | - | 534 K | 251 K | 1.73 M | - | 1.97 M | 1.79 M | 1.57 M | - | 1.47 M | 1.54 M | 1.6 M | - | 1.18 M | 1.36 M | 1.43 M | - | - | - | - | - | 525 K | - | - | - | 192 K | 564 K | 474 K | - | 244 K | 248 K | 243 K | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-67.5 M | -71.9 M | -65.7 M | - | -64.2 M | -67.6 M | -61.1 M | - | -58.5 M | -54.2 M | -42.6 M | - | -48.8 M | -33.3 M | -38.5 M | -59.2 M | -27.1 M | -23.5 M | -24 M | -19.6 M | -19.1 M | -18.2 M | -18.8 M | -26.5 M | -15.2 M | -14.8 M | -14.3 M | -6.66 M | -6.66 M | -3.47 M | -2.84 M | - | -10.7 M | -8.74 M | -10.1 M | - | -5.43 M | -3.68 M | -3.05 M | - | -2.09 M | -2.19 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
69.4 M | 73.7 M | 67.4 M | - | 65.4 M | 68.8 M | 62.2 M | - | 58.5 M | 54.2 M | 42.6 M | - | 49.6 M | 34 M | 39.2 M | 59.2 M | 27.4 M | 23.6 M | 24.1 M | 19.6 M | 19.2 M | 18.4 M | 18.9 M | 26.5 M | 15.3 M | 14.9 M | 14.4 M | 6.66 M | 6.72 M | 3.52 M | 2.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
27.1 M | 27.4 M | 22.1 M | - | 18.6 M | 17.4 M | 15.8 M | - | 15.1 M | 12.9 M | 11.8 M | - | 10 M | 9.52 M | 10.9 M | - | 5.73 M | 6.83 M | 7.16 M | - | 4.34 M | 4.4 M | 3.81 M | - | 2.27 M | 4.1 M | 8.66 M | - | 1.83 M | 702 K | 585 K | - | 2.31 M | 2.32 M | 2.52 M | - | 1.82 M | 1.73 M | 1.98 M | - | 843 K | 332 K | 162 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency